PTC Therapeutics, Inc. PTCT
$59.97
-6.97%
at last close
Analyst Consensus
- Consensus Rating
- Buy (10 Buy · 1 Hold · 1 Sell)
- Average Price Target
- $96.75
- Implied Upside
- +61.3%
- Price Target Range
- $50.00 – $137.00
- Analysts (12 mo)
- 12
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-15 | UBSJohn Lee |
Assumes | Buy | $80 → $90 |
| 2026-10-08 | RBC CapitalBrian Abrahams |
Maintains | Sector perform | $85 → $75 |
| 2026-09-22 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $130 → $137 |
| 2026-09-14 | Leerink Partners |
Assumes | Outperform | $98 |
| 2026-08-14 | BarclaysEliana Merle |
Maintains | Overweight | $120 → $122 |
| 2026-08-13 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $106 → $109 |
| 2026-07-31 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $93 → $104 |
| 2026-07-31 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $93 → $106 |
| 2026-07-20 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $95 → $93 |
| 2026-07-16 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $124 → $130 |
| 2026-07-07 | RBC CapitalBrian Abrahams |
Maintains | Sector perform | $82 → $85 |
| 2026-06-09 | CitigroupGeoff Meacham |
Assumes | Neutral → Buy | $75 → $108 |
| 2026-05-27 | JefferiesFaisal Khurshid |
Upgrades | Hold → Buy | $76 → $85 |
| 2026-05-08 | TD CowenJoseph Thome |
Upgrades | Hold → Buy | $75 → $90 |
| 2026-05-08 | RBC CapitalBrian Abrahams |
Maintains | Sector perform | $81 → $82 |
| 2026-05-08 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $86 → $95 |
| 2026-03-30 | JefferiesFaisal Khurshid |
Downgrades | Buy → Hold | $91 → $76 |
| 2026-02-23 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $90 → $92 |
| 2026-02-20 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $93 → $86 |
| 2026-02-20 | RBC CapitalBrian Abrahams |
Maintains | Sector perform | $87 → $82 |
| 2026-02-20 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $97 → $93 |
| 2026-01-28 | BarclaysEliana Merle |
Upgrades | Equal-weight → Overweight | $68 → $119 |
| 2025-12-01 | RBC CapitalBrian Abrahams |
Downgrades | Outperform → Sector perform | $82 → $91 |
| 2025-11-06 | BarclaysGena Wang |
Maintains | Equal-weight | $46 → $68 |
| 2025-11-05 | CitigroupGeoff Meacham |
Maintains | Neutral | $50 → $75 |
| 2025-11-05 | TD CowenJoseph Thome |
Maintains | Hold | $50 → $63 |
| 2025-11-05 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $70 → $82 |
| 2025-11-05 | Goldman SachsPaul Choi |
Maintains | Sell | $44 → $50 |
| 2025-11-05 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $73 → $93 |
| 2025-10-28 | JefferiesKelly Shi |
Maintains | Buy | $63 → $77 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $59.97
- Market Cap
- $5.38 billion
- 52-Week Range
- $57.74 – $90.87
- Average Volume
- 1.14 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.